W-2719

N/A

Report date: 2023/02/18 19:46:47
NME

Base Information

Drug NameW-2719
Drug Alias NameW-2719
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDermatitis, Allergic Contact
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMeda Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMeda Ab
Active IndicationsN/A
Inactive IndicationsDermatitis, Allergic Contact

Other Information

ATC CodeN/A
Related LinksN/A